NORPRAMIN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Norpramin, and when can generic versions of Norpramin launch?

Norpramin is a drug marketed by Validus Pharms and is included in one NDA.

The generic ingredient in NORPRAMIN is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Norpramin

A generic version of NORPRAMIN was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5^th, 1987.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NORPRAMIN?
What are the global sales for NORPRAMIN?
What is Average Wholesale Price for NORPRAMIN?

Summary for NORPRAMIN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	89
Clinical Trials:	10
Patent Applications:	1,509
Drug Prices:	Drug price information for NORPRAMIN
What excipients (inactive ingredients) are in NORPRAMIN?	NORPRAMIN excipients list
DailyMed Link:	NORPRAMIN at DailyMed

Drug patent expirations by year for NORPRAMIN

Recent Clinical Trials for NORPRAMIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Stanford University	Phase 4
National Cancer Institute (NCI)	N/A
Albert Einstein College of Medicine of Yeshiva University	N/A

See all NORPRAMIN clinical trials

Pharmacology for NORPRAMIN

Drug Class	Tricyclic Antidepressant

US Patents and Regulatory Information for NORPRAMIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-007	Feb 11, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-004	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-003	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-006	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-005	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NORPRAMIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-007	Feb 11, 1982	⤷ Sign Up	⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Validus Pharms	NORPRAMIN	desipramine hydrochloride	TABLET;ORAL	014399-005	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NORPRAMIN

See the table below for patents covering NORPRAMIN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
France	1445454	Nouveaux dérivés d'iminodibenzyle et leur préparation	⤷ Sign Up
Spain	267641		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for NORPRAMIN

Recent Clinical Trials for NORPRAMIN

Pharmacology for NORPRAMIN

Make Better Decisions: Try a trial or see plans & pricing